Since KRAS4A is enriched particularly in a sub-population of cells with stem cell properties, our data suggest a model in which coordination of the stem-progenitor cell transition in cancers may be achieved through regulation of KRAS mRNA splicing, identifying a potential vulnerability in KRAS mutant tumors. The gene discussed is KRAS; the disease is cancer.